SB-334867 free base
CAS No. 792173-99-0
SB-334867 free base( SB334867A free base | SB334867 free base | SB 334867 free base )
Catalog No. M15972 CAS No. 792173-99-0
The first selective Orexin-1 receptor antagonist with pKb of 7.4.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 67 | In Stock |
|
| 2MG | 33 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 95 | In Stock |
|
| 25MG | 155 | In Stock |
|
| 50MG | 221 | In Stock |
|
| 100MG | 330 | In Stock |
|
| 200MG | 491 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSB-334867 free base
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe first selective Orexin-1 receptor antagonist with pKb of 7.4.
-
DescriptionThe first selective Orexin-1 receptor antagonist with pKb of 7.4; displays 50-fold selectivity over OX2 (pKb 5.7), >100-fold or selectivity over 5-HT2B, 5-HT2C and approximately 50 other molecular targets, in particular GPCRs and ion channels; possesses CNS penetration, in vivo activity following ip dosing.Obesity Preclinical.
-
In Vitro——
-
In VivoAnimal Model:Male Swiss mice Dosage:20?mg/kg Administration:Intraperitoneal injectionResult:Inhibited the acquisition of morphine-induced sensitization to locomotor activity of mice.Animal Model:C57BL/6J Mice Dosage:3, 10 and 30 mg/kg Administration:Intraperitoneal injectionResult:Reduced ethanol consumption, BECs and suppressed sucrose intake in mice.
-
SynonymsSB334867A free base | SB334867 free base | SB 334867 free base
-
PathwayGPCR/G Protein
-
TargetOrexin Receptor
-
RecptorOX1
-
Research AreaMetabolic Disease
-
IndicationObesity
Chemical Information
-
CAS Number792173-99-0
-
Formula Weight319.3174
-
Molecular FormulaC17H13N5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 49 mg/mL
-
SMILESCC1=NC2=C(O1)C=C(C=C2)NC(=O)NC3=C4C(=NC=C3)C=CC=N4
-
Chemical NameUrea, N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Smart D, et al. Br J Pharmacol. 2001 Mar;132(6):1179-82.
2. Porter RA, et al. Bioorg Med Chem Lett. 2001 Jul 23;11(14):1907-10.
3. Rodgers RJ, et al. Eur J Neurosci. 2001 Apr;13(7):1444-52.
molnova catalog
related products
-
MK-3697
MK-3697 is a potent, selective, orally bioavailable Orexin 2 receptor (OX2R) antagonist with Ki of 1.1 nM and IC50 of 16 nM.
-
[Ala11,D-Leu15]-Orex...
Highly potent and selective OX2 receptor agonist; displays 400-fold selectivity over OX1 receptors. EC50 values are 0.13 and 52 nM for human OX2 and OX1 receptors respectively.
-
Seltorexant
A potent, selective, orally active orexin-2 receptor (OX2R) antagonist with pKi of 8.0 and 8.1 for human and rat OX2R, respectively.
Cart
sales@molnova.com